• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

    6.205 -1.285 (-17.16%)
    Streaming Delayed Price Updated: 12:29 PM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 245,177
    Open 7.340
    Bid (Size) 6.120 (100)
    Ask (Size) 6.290 (300)
    Prev. Close 7.490
    Today's Range 6.126 - 7.500
    52wk Range 7.170 - 69.00
    Shares Outstanding 13,012,866
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire

    Performance

    YTD
    -69.8%
    -69.8%
    1 Month
    -74.5%
    -74.5%
    3 Month
    -75.6%
    -75.6%
    6 Month
    -70.7%
    -70.7%
    1 Year
    -71.4%
    -71.4%

    More News

    Read More
    News headline image
    RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    REGENCELL DEADLINE JUNE 23rd: Bragar Eagel & Squire, P.C. Urgently Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    REGENCELL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    REGENCELL DEADLINE TUESDAY JUNE 23rd: Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited (NASDAQ:RGC) Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    REGENCELL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100Kto Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    REGENCELL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Reminds Regencell Bioscience Holdings Limited Investors They Have Until June 23rd to Contact the Firm Seeking Lead Plaintiff Role
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
    From Levi & Korsinsky, LLP
    Via Business Wire
    News headline image
    Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm Before June 23rd
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights
    From Robbins LLP
    Via Business Wire
    News headline image
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
    From Pomerantz LLP
    Via GlobeNewswire

    Frequently Asked Questions

    Is Regencell Bioscience Holdings Limited - Ordinary Shares publicly traded?
    Yes, Regencell Bioscience Holdings Limited - Ordinary Shares is publicly traded.
    What exchange does Regencell Bioscience Holdings Limited - Ordinary Shares trade on?
    Regencell Bioscience Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares?
    The ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares is RGC on the Nasdaq Stock Market
    What is the current price of Regencell Bioscience Holdings Limited - Ordinary Shares?
    The current price of Regencell Bioscience Holdings Limited - Ordinary Shares is 6.205
    When was Regencell Bioscience Holdings Limited - Ordinary Shares last traded?
    The last trade of Regencell Bioscience Holdings Limited - Ordinary Shares was at 06/26/26 12:29 PM ET
    What is the market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares?
    The market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares is 80.74M
    How many shares of Regencell Bioscience Holdings Limited - Ordinary Shares are outstanding?
    Regencell Bioscience Holdings Limited - Ordinary Shares has 81M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.